Under the competition, six start-up firms will be given 100 days to further develop their innovative health solutions. Bayer will also support them with offices in Berlin, expert mentoring, and 57,917 dollars each in funding.
Berlin/Germany – Changing the experience of health: that’s the focus of the six startups which the Bayer G4A team has included in the Accelerator programme this year. The young companies from Canada, Germany, Israel, Spain, the United Kingdom and the United States came out ahead of more than 1,800 competitors from 100 countries.
They now have 100 days in which to intensively drive the further development of their products and solutions with expertise and investment from Bayer. The company will provide them with offices in Berlin, pharmaceutical executives and industry experts as mentors and 57,917 dollars funding for each project.
Digital solutions are essential to driving innovation in an evolving healthcare environment. Bayer is seeking to apply them across the pharmaceutical value chain in order to detect diseases at an earlier stage, to develop medicines faster, and to deliver individual treatments with a meaningful outcome for patients.
In this endeavor, the company will benefit immensely from collaborations and the exchange of knowledge and skills with innovative start-ups. Cooperation with startups is an integral part of Bayer’s overall digital transformation. The company is driving a Group-wide initiative called ‘Advancing Digital’ to foster innovative solutions in healthcare and agriculture.
Six years ago, the firm started cooperating with startups in the healthcare sector through the G4A programme headed by Eugene Borukhovich. The startups that have applied are developing digital solutions that cover the entire value chain within healthcare. Also this year, a patient jury was asked to rank startups according to the impact that their solutions would have on patient experience.
This year’s winners are:
• Agamon (Israel, GB): A healthcare intelligence platform that can be used to compile and structure health-related data from various sources in order to derive new information. www.agamon.io
• Cyclica (Canada): A cloud platform that aims to use artificial intelligence and biophysics to accelerate drug development. www.cyclicarx.com
• Kinaptic (USA): An accelerated learning system for VR stroke rehabilitation using electric stimulation that analyzes and detects neural signals to stimulate nerves in stroke patients. www.kinaptic.com
• OME (GB): Personalized health coaching that uses extensive data analyses to compile individualised health programmes (nutrition, sleep, physical activity) in order to prevent disease. www.ome.health
• S-There Technologies (Spain): A smart device that analyzes health data through urine in the toilet and gives patients insights into their health. https://s-there.com/
• Zencorlabs (Germany): A smartphone software and device that uses artificial intelligence to warn patients of heart failure.